Phase I/II Study of Neoadjuvant Chemoradiotherapy Consisting of S-1 and Cisplatin for Patients with Clinically Resectable Type 4 or Large Type 3 Gastric Cancer (OGSG1205)

To improve the prognosis of clinically resectable type 4 or large type 3 gastric cancer (GC), we performed a phase I/II study of neoadjuvant-radiotherapy combined with S-1 plus cisplatin. Phase I, with a standard 3 + 3 dose-escalation design, was performed to define the recommended phase II dose. Ef...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of surgical oncology 2025-01
Hauptverfasser:	Shinkai, Masayuki, Imano, Motohiro, Yokokawa, Masaki, Tanaka, Ryo, Matsuyama, Jin, Shimokawa, Toshio, Kawakami, Hisato, Satoh, Taroh, Yasuda, Takushi, Furukawa, Hiroshi
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!